Nationwide
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
National Cancer Institute (NCI)
Ph 2·~5yr·1 site in MD
Enrolling now
Check if I qualifyShowing 1–24 of 71 trials
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Aura Biosciences
Clasp Therapeutics, Inc.
Daiichi Sankyo
Totus Medicines
BeiGene
Abramson Cancer Center at Penn Medicine
Cedars-Sinai Medical Center
Icahn School of Medicine at Mount Sinai
The Methodist Hospital Research Institute
University of California, Los Angeles
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, San Francisco
University of Florida
Merck Sharp & Dohme LLC
UNC Lineberger Comprehensive Cancer Center
VA Office of Research and Development